22NW, LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
22NW, LP disclosed 21 US equity positions worth $212.3m in its Q3 2025 13F filing. The largest position was ANEB at 18.2% of the reported book, followed by FSTR and LFCR. Against the Q2 2025 filing, it opened 2 new positions, added to 4 and reduced 4 among the top 21 holdings.
What did 22NW, LP own in Q3 2025? Top 21 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ANEB ANEBULO PHARMACEUTICALS INC | 18.2% | $38.7m | 15,467,300 | 0% | held | |
| 2 | FSTR FOSTER L B CO | Industrials | 16.7% | $35.4m | 1,313,121 | 0% | held |
| 3 | LFCR LIFECORE BIOMEDICAL INC | 9.5% | $20.1m | 1,254 | -100% | reduced | |
| 4 | NKTR NEKTAR THERAPEUTICS | Healthcare | 8.9% | $18.8m | 331,115 | 127% | added |
| 5 | SRI STONERIDGE INC | Consumer Cyclical | 7.6% | $16.0m | 2,105,600 | 8% | added |
| 6 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 6.4% | $13.6m | 358,325 | -36% | reduced |
| 7 | RGNX REGENXBIO INC | Healthcare | 4.2% | $8.9m | 923,679 | 0% | held |
| 8 | CULP CULP INC | 3.9% | $8.3m | 1,859,061 | 0% | held | |
| 9 | RZLT REZOLUTE INC | 3.6% | $7.7m | 820,653 | – | new | |
| 10 | DHX DHI GROUP INC | Technology | 2.7% | $5.7m | 2,036,988 | -38% | reduced |
| 11 | PHENIXFIN CORP | 2.6% | $5.6m | 117,885 | 0% | held | |
| 12 | MEC MAYVILLE ENGR CO INC | 2.6% | $5.5m | 399,890 | 157% | added | |
| 13 | MGTX MEIRAGTX HLDGS PLC | 2.3% | $4.8m | 586,519 | 0% | held | |
| 14 | UFI UNIFI INC | Consumer Cyclical | 2.2% | $4.7m | 977,639 | -0% | held |
| 15 | CMT CORE MOLDING TECHNOLOGIES IN | 2.2% | $4.6m | 222,738 | 16% | added | |
| 16 | AEBI SCHMIDT HLDG AG | 2.0% | $4.3m | 347,840 | – | new | |
| 17 | FB1 FARMER BROS CO | 1.6% | $3.3m | 1,955,526 | 0% | held | |
| 18 | TISI TEAM INC | 1.3% | $2.8m | 170,187 | -1% | reduced | |
| 19 | ELDN ELEDON PHARMACEUTICALS INC | 0.8% | $1.6m | 636,364 | 0% | held | |
| 20 | SSKN STRATA SKIN SCIENCES INC | 0.5% | $1.1m | 536,995 | 0% | held | |
| 21 | PSYCHEMEDICS CORPORATION CMN | 0.3% | $582.4k | 276,034 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.